Medicare Enrolled
Ashleigh Gehret, FNP-C
Nurse Practitioner - Family · Reading, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Gehret from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Gehret?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Gehret
Ashleigh Gehret is a nurse practitioner - family in Reading, PA, with 7 years of NPI registration. Based on federal Medicare data, Gehret performed 2,158 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Gehret received a total of $6,938 from 53 pharmaceutical and/or device companies across 379 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Gehret is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 7 years of NPI registration
▲ Top 2% volume in PA
$6,938 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,158
Medicare services
Top 2% in PA for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 720 | $18 | $37 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $71 | $190 |
| Annual alcohol misuse screening, 5 to 15 minutes | 171 | $15 | $27 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
162 | $43 | $134 |
| Annual depression screening | 141 | $15 | $27 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
128 | $100 | $185 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
61 | $78 | $220 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
60 | $21 | $61 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
60 | $20 | $35 |
| Home visit, established patient, moderate complexity A home visit for an established patient involving moderate medical decision making. The visit requires at least 40 minutes of time if time is used to determine the level of service. |
32 | $74 | $200 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
28 | $19 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
23 | $8 | $37 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
22 | $7 | $65 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $179 | $381 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
16 | $23 | $85 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $108 | $270 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $122 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,938
Total received (2021-2024)
Avg $1,735/year across 4 years
Top 3% in PA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
379
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,077
2023
$2,176
2022
$1,518
2021
$1,167
Payments by company (2024)
ABBVIE INC.
$567
AstraZeneca Pharmaceuticals LP
$238
Novo Nordisk Inc
$196
PFIZER INC.
$192
Lilly USA, LLC
$186
Novartis Pharmaceuticals Corporation
$151
Amgen Inc.
$106
SHIELD THERAPEUTICS INC
$97
Astellas Pharma US Inc
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
GlaxoSmithKline, LLC.
$39
Lundbeck LLC
$29
Daiichi Sankyo Inc.
$28
Sumitomo Pharma America, Inc.
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Abbott Laboratories
$20
Bayer Healthcare Pharmaceuticals Inc.
$17
Currax Pharmaceuticals LLC
$14
Phathom Pharmaceuticals, Inc.
$14
Top 3 companies account for 48.2% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,172
Novo Nordisk Inc
$1,012
Amgen Inc.
$528
PFIZER INC.
$417
Lilly USA, LLC
$391
AstraZeneca Pharmaceuticals LP
$375
Amarin Pharma Inc.
$286
Novartis Pharmaceuticals Corporation
$233
Boehringer Ingelheim Pharmaceuticals, Inc.
$185
SANOFI-AVENTIS U.S. LLC
$175
Astellas Pharma US Inc
$167
AbbVie Inc.
$167
GlaxoSmithKline, LLC.
$156
Merck Sharp & Dohme LLC
$106
Teva Pharmaceuticals USA, Inc.
$105
Daiichi Sankyo Inc.
$105
SHIELD THERAPEUTICS INC
$97
Lundbeck LLC
$86
Bayer Healthcare Pharmaceuticals Inc.
$79
MAYNE PHARMA COMMERCIAL LLC
$69
Merck Sharp & Dohme Corporation
$63
IBSA Pharma Inc.
$62
Biohaven Pharmaceuticals, Inc.
$61
Biogen, Inc.
$57
Paratek Pharmaceuticals, Inc.
$56
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$55
Sunovion Pharmaceuticals Inc.
$51
Abbott Laboratories
$44
Bayer HealthCare Pharmaceuticals Inc.
$41
Esperion Therapeutics, Inc.
$39
Shield Therapeutics Inc
$36
Currax Pharmaceuticals LLC
$32
Takeda Pharmaceuticals U.S.A., Inc.
$30
IMPEL PHARMACEUTICALS INC.
$29
Biohaven Pharmaceutical Holding Company Ltd.
$27
Sumitomo Pharma America, Inc.
$27
Kowa Pharmaceuticals America, Inc.
$26
Otsuka America Pharmaceutical, Inc.
$26
Collegium Pharmaceutical, Inc.
$24
VBI Vaccines (Delaware) Inc.
$21
Alnylam Pharmaceuticals Inc.
$20
IDORSIA PHARMACEUTICALS US INC
$20
SANOFI PASTEUR INC.
$20
Mannkind Corporation
$20
SI-BONE, INC.
$20
Avanir Pharmaceuticals, Inc.
$20
Janssen Pharmaceuticals, Inc
$17
UROVANT SCIENCES INC
$15
Amneal Pharmaceuticals LLC
$14
Exact Sciences Corporation
$14
Phathom Pharmaceuticals, Inc.
$14
BioDelivery Sciences International, Inc.
$13
Philips Electronics North America Corporation
$12
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · ADUHELM · AFREZZA · AIRSUPRA · AJOVY · ANORO ELLIPTA · AUSTEDO · Aimovig · Austedo XR · BELBUCA · BELSOMRA · BOTOX · BREZTRI · COMIRNATY · CONTRAVE · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · GEMTESA · IFUSE IMPLANT · INJECTAFER · JARDIANCE · Kerendia · LATUDA · LEQVIO · LICART · LINZESS · LOKELMA · Livalo · M-M-R II · MOUNJARO · Myrbetriq · NEXLETOL · NUEDEXTA · NURTEC ODT · NUZYRA · ONPATTRO · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STEGLATRO · STIOLTO RESPIMAT · SYNJARDY · SYNTHROID · Saxenda · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tirosint · Trudhesa · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XTAMPZA · ZOMIG
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
432
County median income
$77,684
Nearest hospital to ZIP centroid (approximate)
READING HOSPITAL
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Gehret is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Gehret experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Gehret performed 720 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Gehret receive payments from pharmaceutical companies?
Yes. Gehret received a total of $6,938 from 53 companies across 379 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Gehret's costs compare to other family nurse practitioners in Reading?
Gehret's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Gehret) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Reading
Browse family nurse practitioners in Reading ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in PA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in PA
Which PA family nurse practitioners receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology